Soluble epoxide hydrolase: a new therapeutic target for depression

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

(2016) Jerome Sarris et al.   AMERICAN JOURNAL OF PSYCHIATRY

Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets

(2016) Ji-chun Zhang et al.   Current Neuropharmacology

Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress

(2016) Qian Ren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inflammatory Biomarkers as Differential Predictors of Antidepressant Response

(2015) Kenji Hashimoto   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

(2015) Ji-chun Zhang et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells

(2015) M. A. Horowitz et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides

(2014) Cristina López-Vicario et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling

(2014) Karen Wagner et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer

(2013) Guodong Zhang et al.   PROGRESS IN LIPID RESEARCH

Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

(2012) Christophe Morisseau et al.   Annual Review of Pharmacology and Toxicology

Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation and severity of depression

(2012) P-Y Lin et al.   MOLECULAR PSYCHIATRY

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

(2009) John D. Imig et al.   NATURE REVIEWS DRUG DISCOVERY

Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism

(2009) A. Marowsky et al.   NEUROSCIENCE

Epoxyeicosanoid signaling in CNS function and disease

(2009) Jeffrey J. Iliff et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS